A detailed history of Morgan Stanley transactions in Lifevantage Corp stock. As of the latest transaction made, Morgan Stanley holds 14,932 shares of LFVN stock, worth $206,509. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,932
Previous 16,869 11.48%
Holding current value
$206,509
Previous $108,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.51 - $13.01 $10,672 - $25,200
-1,937 Reduced 11.48%
14,932 $180,000
Q2 2024

Oct 17, 2024

SELL
$5.75 - $7.95 $4,111 - $5,684
-715 Reduced 4.07%
16,869 $108,000
Q2 2024

Aug 14, 2024

SELL
$5.75 - $7.95 $4,111 - $5,684
-715 Reduced 4.07%
16,869 $108,000
Q1 2024

Oct 17, 2024

BUY
$5.31 - $7.01 $3,796 - $5,012
715 Added 4.24%
17,584 $106,000
Q1 2024

Aug 16, 2024

BUY
$5.31 - $7.01 $998 - $1,317
188 Added 1.08%
17,584 $106,000
Q1 2024

May 15, 2024

BUY
$5.31 - $7.01 $998 - $1,317
188 Added 1.08%
17,584 $106,000
Q4 2023

Aug 16, 2024

BUY
$4.38 - $8.25 $2,308 - $4,347
527 Added 3.12%
17,396 $104,000
Q4 2023

Feb 13, 2024

BUY
$4.38 - $8.25 $8,663 - $16,318
1,978 Added 12.83%
17,396 $104,000
Q3 2023

Nov 15, 2023

SELL
$4.22 - $7.51 $20,994 - $37,362
-4,975 Reduced 24.4%
15,418 $99,000
Q2 2023

Aug 14, 2023

SELL
$3.04 - $5.5 $48,044 - $86,922
-15,804 Reduced 43.66%
20,393 $88,000
Q1 2023

May 15, 2023

SELL
$3.26 - $4.0 $5,010 - $6,148
-1,537 Reduced 4.07%
36,197 $129,000
Q4 2022

Feb 14, 2023

SELL
$3.63 - $4.03 $80,745 - $89,643
-22,244 Reduced 37.09%
37,734 $140,000
Q3 2022

Nov 14, 2022

SELL
$3.48 - $4.51 $32,141 - $41,654
-9,236 Reduced 13.34%
59,978 $226,000
Q2 2022

Oct 27, 2022

SELL
$3.82 - $4.89 $61,582 - $78,831
-16,121 Reduced 18.89%
69,214 $301,000
Q2 2022

Aug 15, 2022

SELL
$3.82 - $4.89 $61,582 - $78,831
-16,121 Reduced 18.89%
69,214 $301,000
Q1 2022

Oct 27, 2022

BUY
$4.74 - $6.68 $76,413 - $107,688
16,121 Added 23.29%
85,335 $406,000
Q1 2022

May 13, 2022

BUY
$4.74 - $6.68 $8,588 - $12,104
1,812 Added 2.17%
85,335 $406,000
Q4 2021

Feb 14, 2022

SELL
$6.15 - $7.68 $732,840 - $915,156
-119,161 Reduced 58.79%
83,523 $527,000
Q3 2021

Nov 15, 2021

BUY
$6.5 - $8.38 $1.32 Million - $1.7 Million
202,684 New
202,684 $1.37 Million

Others Institutions Holding LFVN

About Lifevantage Corp


  • Ticker LFVN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 12,560,000
  • Market Cap $174M
  • Description
  • LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...
More about LFVN
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.